United States Biotechnology & Medical Research

Apnimed Inc (APMD)

Track

Apnimed Inc witnessed two significant insider purchases totaling 5.2 million dollars on August 3, 2026. Paul J. Sekhri acquired shares worth 200,000 dollars, while Morningside Venture Investments Ltd invested 5 million dollars. These acquisitions occurred amid a 68.8 percent stock price increase over the past ninety days, despite no recent public disclosure regarding the latest earnings report.
Ticker: APMD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 3 Aug 2026
Value US$1,287,600.57 | Price 30.56 | Shares 31,702 (-18.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03 B Purchase
3.5
Morningside Venture Investments Ltd
Large shareholder
31,702 -18.4%
30.56
US$1,287,601 		31,702 -18.4% 30.56 US$1,287,601
2026-08-03 2026-08-03 B Purchase
2.9
SEKHRI PAUL J
Non-Executive Director
94,755 -14.7%
401.91
US$3,894,750 		94,755 -14.7% 401.91 US$3,894,750
Explore more

More insider trading research around Apnimed Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America